Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains
- 24 December 2002
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 21 (1) , 39-48
- https://doi.org/10.1016/s0924-8579(02)00274-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Chemotherapy of Chagas DiseaseCurrent Pharmaceutical Design, 2002
- Specific treatment of Chagas disease: current status and new developmentsCurrent Opinion in Infectious Diseases, 2001
- Parasite persistence in the aetiology of Chagas diseaseInternational Journal for Parasitology, 2001
- Parasitology:The Dawn of a New MillenniumParasitology Today, 2000
- Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in ArgentinaMemórias do Instituto Oswaldo Cruz, 1999
- Parasitological cure of Chagas disease: is it possible? Is it relevant?Memórias do Instituto Oswaldo Cruz, 1999
- Chagas Disease Etiology: Autoimmunity or Parasite Persistence?Parasitology Today, 1999
- Chemotherapy of Chagas' disease: the how and the whyJournal of Molecular Medicine, 1999
- Immnunological Control of Trypanosoma cruzi Infection and Pathogenesis of Chagas’ DiseaseInternational Archives of Allergy and Immunology, 1997
- Avaliação da atividade terapêutica do itraconazol nas infecções crônicas, experimental e humana, pelo Trypanosoma cruziRevista do Instituto de Medicina Tropical de São Paulo, 1992